Cargando…
On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models
In translational oncology research, the patient-derived xenograft (PDX) model and its use in mouse clinical trials (MCT) are increasingly described. This involves transplanting a human tumor into a mouse and studying its evolution during follow-up or until death. A MCT contains several PDXs in which...
Autores principales: | Savel, Hélène, Barbier, Sandrine, Proust-Lima, Cécile, Rondeau, Virginie, Thiébaut, Rodolphe, Meyer-Losic, Florence, Richert, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035449/ https://www.ncbi.nlm.nih.gov/pubmed/36968232 http://dx.doi.org/10.1158/2767-9764.CRC-22-0238 |
Ejemplares similares
-
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
por: Barbier, Sandrine, et al.
Publicado: (2023) -
Disease progression model anchored around clinical diagnosis in longitudinal cohorts: example of Alzheimer’s disease and related dementia
por: Lespinasse, Jérémie, et al.
Publicado: (2023) -
Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model
por: Li, Zhanrong, et al.
Publicado: (2012) -
Antitumor effect of FP3 in a breast cancer xenograft model
por: LAN, HUANRONG, et al.
Publicado: (2013) -
Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
por: Huynh, Hung, et al.
Publicado: (2015)